What is the CVR number of ROS Therapeutics ApS?

ROS Therapeutics ApS is registered with CVR / Virk under CVR 39507501.

What is the revenue of ROS Therapeutics ApS?

ROS Therapeutics ApS reported revenue of DKK -584K in 2024.

ROS Therapeutics ApS employs 1 people as of the latest annual report.

Hanne Damgaard Jensen is the CEO of ROS Therapeutics ApS.

Ulrik Spork chairs the board of ROS Therapeutics ApS.

ROS Therapeutics ApS's registered address is Veddelev Engvej 6.

APSActive

CVR 39507501Veddelev Engvej 6, 4000 RoskildeManufacture of pharmaceutical preparations· NACE 2120Est. 2018 · 8 years old1 employees

Actively employed in the business

Name	Role	Member since
Current (1)
HD Hanne Damgaard Jensen Chief Executive Officer	Chief Executive Officer	2018

Non-executive oversight

Name	Role	Member since
Current (4)
HC Henrik Castenholm Fenger Board of Directors	Board of Directors	2022
MA Morten Amstrup Sandlykke Board of Directors	Board of Directors	2020
RB Ricki Boye Board of Directors	Board of Directors	2019
US Ulrik Spork Chairman	Chairman	2018
Former (4)
MH Mads Hartvig Clausen Board of Directors	Board of Directors	2018 – 2019
CP Christian Philip Hansen Board of Directors	Board of Directors	2018 – 2018
AG Anker Gunvald Lundemose Board of Directors	Board of Directors	2018 – 2019
JB Jon Bondebjerg Board of Directors	Board of Directors	2018 – 2019

As of last annual report

Shareholder	Type	Ownership	Votes	Since
ROS Therapeutics Holding ApS	Company	50–66.65%	50–66.65%	2020
Sandlykke A/S	Company	10–14.99%	10–14.99%	2020
HDJ & LEJ Invest ApS	Company	5–9.99%	5–9.99%	2020
ROS Therapeutics ApS	Company	10–14.99%	10–14.99%	2018
SPORCON LIFESCIENCE ADVISORS ApS	Company	10–14.99%	10–14.99%	2019
INNOVATIONS A/S	Company	5–9.99%	5–9.99%	2018
Rasmus Wilhelmsen	Individual	5–9.99%	5–9.99%	2018
GreenOcean Capital ApS	Company	5–9.99%	5–9.99%	2018

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.